EvanSamuelCantorMDJD

Pediatrics • Hartford, CT

Pediatric Hematology/Oncology

Fellow, Pediatric Neuro-Oncology

Join to view full profile

Dr. Cantor is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Cantor's full profile

Already have an account?

Office
282 Washington Street
Hartford, CT 06106
Phone+1 860-545-9630

Summary

Dr. Evan Cantor is a pediatric hematologist/oncologist in Hartford Connecticut specializing in neuro-oncology. His training has included hematology/oncology fellowship at Michigan Medicine and neuro-oncology fellowship at Washington University in St. Louis. He received his medical degree from Ben Gurion University of the Negev and has been in practice 8 years. He has 9 publications.

Education & Training

Barnes-Jewish HospitalPediatric Neuro-Oncology, 2021 - 2022
University of MichiganFellowship, Pediatric Hematology/Oncology, 2018 - 2021
NYU Grossman Long Island School of MedicineResidency, Pediatrics, 2014 - 2018
Ben Gurion University of the NegevClass of 2014

Certifications & Licensure

CT State Medical License 2022 - 2024
MO State Medical License 2021 - 2023
MI State Medical License 2018 - 2022
NY State Medical License 2017 - 2022
American Board of Pediatrics Pediatrics

Publications & Presentations

PubMed

29 citations
Electronic DNA Analysis of CSF Cell-free Tumor DNA to Quantify Multi-gene Molecular Response in Pediatric High-grade Glioma.
Amy K. Bruzek, Karthik Ravi, Ashwath Muruganand, Jack Wadden, Clarissa Babila
Clinical Cancer Research. 2020-10-21
20 citations
Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy.
Sharon L Gardner, Rohinton S Tarapore, Jeffrey Allen, Susan L McGovern, Wafik Zaky
Neuro-Oncology Advances. 2022-09-13
18 citations
A novel ATXN1-DUX4 fusion expands the spectrum of 'CIC-rearranged sarcoma' of the CNS to include non-CIC alterations.
Drew Pratt, Chandan Kumar-Sinha, Marcin Cieślik, Rohit Mehra, Hong Xiao
Acta Neuropathologica. 2021-02-07

Press Mentions

Spinal Fluid Sampling Could Provide Data About Tumors Sooner Than MRIsMarch 24th, 2022
Chimerix Announces Upcoming Presentations at the American Society of Clinical Oncology 2021 Annual MeetingMay 19th, 2021